Largest, Most Advanced HIV Vaccine Trial for South Africa
The experimental HVTN 702 vaccine, which will be the focus of a trial involving 5,400 sexually active men and women between the ages of 18 and 35, "holds great promise".
(file photo).
-
South Africa:
HIV Vaccine Trial to Begin
VOA, 28 November 2016
A new clinical trial is underway in South Africa on an experimental vaccine that could safely prevent HIV, the virus that causes AIDS. Read more »
-
Africa:
New HIV Vaccine Trial to Commence in S/Africa
Leadership, 28 November 2016
A new vaccine against HIV, to be tested in a trial to be launched in South Africa Wednesday, could be "the final nail in the coffin" for the disease if it is successful, scientists… Read more »
InFocus
-
Deputy President Cyril Ramaphosa has said that the country will play a "leading role" in a R135 million HIV vaccine trial that aims to reduce transmission of the disease by at ... Read more »